The mission of the Simmons Cancer Center (SCC) Genomics Shared Resource (GSR) is to advise, train and enable members to perform cancer-related research using high throughput genomic and proteomic expression analyses. The GSR facilitates both intra- and inter-programmatic cancer-specific research by offering training and advice on the best use of state-of-the-art genetic and proteomic platforms provided by the University Core. Typical users of the GSR interact within and between various Programs of the Cancer Center. Users of the GSR include members of the UT Southwestern SPORE in lung cancer (Molecular Therapeutics, Cancer Cell Networks, Chemistry and Cancer), The UT Southwestern NSCOR Program (Molecular Therapeutics), the Program Project Grant in Cancer and Chemistry (Chemistry and Cancer), and the various disease-oriented teams in breast and prostate cancers (Molecular Therapeutics, Development and Cancer). Researchers perform experiments in, and share research databases using, cRNA (microarray), siRNA oligomer and/or shRNA lenfiviral-mediated screening, aCGH analyses, SNP analyses, and protein expression microarray analyses provided by the GSR. Cancer Center investigators and their related staff interact direcfiy with the GSR director and technology advisors, as follows: Drs. Michael Story (Genomics: gene and miRNA expression, aCGH, methylation and SNP analyses), Chin-Rang Yang (Proteomics: Qdot RPPM expression analyses), or Dr. Woody Wright (Gene Knockdown: sIRNA and shRNA knockdown analyses), prior to experimentation, through consults to ensure efficient use of resources, including University Core Resources. Future development of the GSR is dependent on input from Cancer Center members, Program and Senior Leaders of the Cancer Center, our internal advisory board members, and recruitment (by internal or external sources) of available technical advisors. The GSR remains flexible in its current and future development, most recently noted by the recent inclusion of Qdot reverse-phase proteomic microarray (Qdot RPPM), shRNA lentiviral library screening, and deep sequencing capability.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-05
Application #
8711035
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
5
Fiscal Year
2014
Total Cost
$56,674
Indirect Cost
$1,855
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851
Rutkowski, Joseph M; Pastor, Johanne; Sun, Kai et al. (2017) Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. Kidney Int 91:324-337
Singh, Jaspal; Rustagi, Vineeta; Zhang, Shanrong et al. (2017) On-bead combinatorial synthesis and imaging of europium(III)-based paraCEST agents aids in identification of chemical features that enhance CEST sensitivity. Magn Reson Chem 55:747-753
Singh, Dinesh K; Kollipara, Rahul K; Vemireddy, Vamsidara et al. (2017) Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Rep 18:961-976
Gu, Yi-Feng; Cohn, Shannon; Christie, Alana et al. (2017) Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discov 7:900-917
Lee, Ming Y; Sumpter Jr, Rhea; Zou, Zhongju et al. (2017) Peroxisomal protein PEX13 functions in selective autophagy. EMBO Rep 18:48-60
Gao, Boning; Huang, Chunxian; Kernstine, Kemp et al. (2017) Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions. Oncotarget 8:11114-11126
Howard, James J; Sturge, Carolyn R; Moustafa, Dina A et al. (2017) Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers. Antimicrob Agents Chemother 61:
Skinner, Celette Sugg; Ahn, Chul; Halm, Ethan A et al. (2017) Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk. Prev Med 102:20-23
Garcia, Sandra; Bisen, Ajit; Yan, Jingsheng et al. (2017) Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity. J Thorac Oncol 12:1489-1495

Showing the most recent 10 out of 441 publications